Similarly, studies by Pavlovic et al. and Lu et al. found that IL-33 promoted the expansion of Tregs, leading to decreased pancreatic inflammation, reduced β-cell apoptosis, and delayed or prevented T1D onset in murine models [144,145]. Here, IL33 is linked to type 1 diabetes mellitus.